Articles

  • 2 weeks ago | onlinelibrary.wiley.com | Hong P. Zhang |Jing Li |Shan Deng

    To the Editor, We sincerely thank (Wang et al. 2025) for their in-depth discussion of our systematic review (Zhang et al. 2025). Their comments provide critical perspectives on the limitations of current research and stimulate further reflection on future directions. We would like to elaborate on the research context, key controversies and strategies for improvement to foster academic consensus.

  • Mar 26, 2025 | nature.com | Rong Lin |Shuo Lin |Xiaona Zheng |Hong P. Zhang |Lili Chen |Tingfang Shao | +3 more

    This study aims to evaluate the effects of a creative expressive art-based storytelling accompanied by caregivers (CrEAS-AC) program on reducing behavioral and psychological symptoms of dementia (BPSD) in older adults with dementia and caregiver burden compared to a general social contact (SC) control group. In this two-arm randomized controlled trial, dyads comprising participants with dementia and their caregivers were randomly assigned to the CrEAS-AC (n = 39) and SC groups (n = 39). Interventions were applied twice per week for 12 weeks. The primary outcomes were BPSD (NPI and AES-I) and caregiver distress, while secondary outcomes included communication ability (SFACS-S and SFACS-C), caregiver burden (CBI), and other health-related outcomes (activities of daily living and QOL-AD). All variables were measured at baseline, 12-week follow-up, and 24-week follow-up. Linear mixed model analyses indicated that participants in the CrEAS-AC group showed significantly lower scores on NPI, AES-I, caregiver distress, and CBI post-intervention at the 12-week follow-up, compared with the SC group. They also showed higher scores on QOL-AD, SFACS-S, and SFACS-C. Baseline characteristics did not modify the effects of the interventions, which were maintained until at least 24-week follow-up. The CrEAS-AC program, as an art-based intervention, is therefore potentially effective in reducing behavioral and psychological symptoms of dementia and improving communication ability and quality of life in older adults with dementia, as well as reducing caregivers’ distress and burden. Trial registration: The study was registered in the Chinese Clinical Trials Registry (ID: ChiCTR2200064838) on 19/10/2022.

  • Oct 22, 2024 | onlinelibrary.wiley.com | Hong P. Zhang |Lei Zhang

    Conflicts of Interest The authors declare no conflicts of interest. References , , and . 2021. “The Wealth Effect of Corporate Water Actions: How Past Corporate Responsibility and Irresponsibility Influence Stock Market Reactions.” Journal of Business Ethics 180: 105–124. https://doi.org/10.1007/s10551-021-04881-6. , and . 2019. “Employee Perspective on CSR: A Review of the Literature and Research Agenda.” Journal of Global Responsibility 10, no. 4: 355–381.

  • Oct 12, 2024 | ift.onlinelibrary.wiley.com | Qing Liang |Xinjiang Production |Yang Liu |Hong P. Zhang

    CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. REFERENCES , & (2021). A new model for estimation of bubble point pressure using a Bayesian optimized least square gradient boosting ensemble. Energies, 14(9), 2653. https://doi.org/10.3390/en14092653 , & (2010). Evaluation of a rapid protein analyzer for determination of protein in milk and cream. Journal of Dairy Science, 93(8), 3846–3857. https://doi.org/10.3168/jds.2009-2959 , , , & (2021).

  • Jul 16, 2024 | preprints.org | Hong P. Zhang

    PreprintTechnical NoteVersion 1This version is not peer-reviewedVersion 1: Received: 16 July 2024 / Approved: 16 July 2024 / Online: 17 July 2024 (04:43:19 CEST)Zhang, H. Immunohistochemistry for Insect Histology and Pathology Diagnosis. Preprints 2024, 2024071354. https://doi.org/10.20944/preprints202407.1354.v1Zhang, H. Immunohistochemistry for Insect Histology and Pathology Diagnosis. Preprints 2024, 2024071354.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →